Mackenzie Financial’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,840
Closed -$239K 1666
2025
Q4
$239K Sell
3,840
-87
-2% -$5.33K ﹤0.01% 1472
2025
Q3
$245K Hold
3,927
﹤0.01% 1482
2025
Q2
$314K Buy
3,927
+50
+1% +$4.18K ﹤0.01% 1378
2025
Q1
$333K Hold
3,877
﹤0.01% 1347
2024
Q4
$303K Hold
3,877
﹤0.01% 1380
2024
Q3
$280K Hold
3,877
﹤0.01% 1227
2024
Q2
$267K Buy
3,877
+106
+3% +$7.18K ﹤0.01% 1214
2024
Q1
$274K Hold
3,771
﹤0.01% 1210
2023
Q4
$231K Hold
3,771
﹤0.01% 1267
2023
Q3
$215K Hold
3,771
﹤0.01% 1253
2023
Q2
$223K Hold
3,771
﹤0.01% 1298
2023
Q1
$236K Hold
3,771
﹤0.01% 1287
2022
Q4
$236K Buy
+3,771
New +$216K ﹤0.01% 1176
2022
Q3
Sell
-3,484
Closed -$205K 1500
2022
Q2
$205K Buy
+3,484
New +$192K ﹤0.01% 1279
2019
Q2
Sell
-97,913
Closed -$2.93M 1215
2019
Q1
$2.93M Buy
+97,913
New +$2.81M 0.01% 686

Other funds holding PBH

Mackenzie Financial's PBH Position: Q1 2026 in Review

Mackenzie Financial sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 3,840 shares — an estimated $239K sold.

Mackenzie Financial first reported a position in PBH in Q1 2019 and held it in 15 quarters. The position peaked at $2.93M in Q1 2019. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Mackenzie Financial reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
  • Mackenzie Financial sold 3,840 Prestige Consumer Healthcare shares in Q1 2026, an estimated $239K.
  • Mackenzie Financial first reported a position in Prestige Consumer Healthcare in Q1 2019 and held it in 15 quarters.
  • Mackenzie Financial's Prestige Consumer Healthcare position peaked at $2.93M in Q1 2019.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.